Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Han, F"" wg kryterium: Autor


Wyświetlanie 1-16 z 16
Tytuł:
Efficacy of concurrent chemoradiotherapy alone for loco-regionally advanced nasopharyngeal carcinoma: long-term follow-up analysis.
Autorzy:
Xu AA; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, No. 78, Hengzhigang Road, Yuexiu District, Guangzhou, 510095, Guangdong, People's Republic of China.
Miao JJ; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 651 Dong Feng Road East, Guangzhou, 510060, China.
Wang L; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 651 Dong Feng Road East, Guangzhou, 510060, China.
Li AC; Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, China.
Han F; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 651 Dong Feng Road East, Guangzhou, 510060, China.
Shao XF; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, No. 78, Hengzhigang Road, Yuexiu District, Guangzhou, 510095, Guangdong, People's Republic of China.
Mo ZW; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, No. 78, Hengzhigang Road, Yuexiu District, Guangzhou, 510095, Guangdong, People's Republic of China.
Huang SM; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 651 Dong Feng Road East, Guangzhou, 510060, China.
Yuan YW; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, No. 78, Hengzhigang Road, Yuexiu District, Guangzhou, 510095, Guangdong, People's Republic of China. .
Deng XW; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 651 Dong Feng Road East, Guangzhou, 510060, China. .
Zhao C; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 651 Dong Feng Road East, Guangzhou, 510060, China. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2023 Apr 05; Vol. 18 (1), pp. 63. Date of Electronic Publication: 2023 Apr 05.
Typ publikacji:
Journal Article
MeSH Terms:
Nasopharyngeal Neoplasms*/radiotherapy
Radiotherapy, Intensity-Modulated*/methods
Humans ; Nasopharyngeal Carcinoma/radiotherapy ; Follow-Up Studies ; Prognosis ; Cisplatin ; Chemoradiotherapy/methods ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Long-term Survivals, Toxicities and the Role of Chemotherapy in Early-Stage Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy: A Retrospective Study with 15-Year Follow-up.
Autorzy:
Wang L; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Miao J; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Huang H; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Chen B; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Xiao X; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Zhu M; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Liang Y; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Xiao W; Department of Radiotherapy, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Huang S; Department of Radiotherapy, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Peng Y; Department of Radiotherapy, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Deng X; Department of Radiotherapy, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Lv X; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Xia W; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Xiang Y; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Guo X; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Han F; Department of Radiotherapy, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Zhao C; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2022 Jan; Vol. 54 (1), pp. 118-129. Date of Electronic Publication: 2021 Jun 07.
Typ publikacji:
Journal Article
MeSH Terms:
Nasopharyngeal Carcinoma/*radiotherapy
Nasopharyngeal Neoplasms/*radiotherapy
Radiotherapy, Intensity-Modulated/*methods
Adult ; Aged ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Nasopharyngeal Carcinoma/drug therapy ; Nasopharyngeal Neoplasms/drug therapy ; Progression-Free Survival ; Radiotherapy, Intensity-Modulated/adverse effects ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Key radioresistance regulation models and marker genes identified by integrated transcriptome analysis in nasopharyngeal carcinoma.
Autorzy:
Sun Z; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of China.
Wang X; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of China.
Wang J; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of China.
Wang J; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of China.
Liu X; GFK biotec.Shanghai Inc.
Huang R; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of China.
Chen C; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of China.
Deng M; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of China.
Wang H; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of China.
Han F; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 Oct; Vol. 10 (20), pp. 7404-7417. Date of Electronic Publication: 2021 Aug 25.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Profiling/*methods
Genetic Markers/*genetics
Nasopharyngeal Neoplasms/*genetics
Radiation Tolerance/*genetics
Adult ; Female ; Humans ; Male ; Middle Aged ; Nasopharyngeal Neoplasms/pathology
Czasopismo naukowe
Tytuł:
Dosimetric parameters predict radiation-induced choanal stenosis in patients with nasopharyngeal carcinoma.
Autorzy:
Chang H; Department of Radiation Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, China.
Chen K; Department of Radiation Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, China.
Tao YL; Department of Radiation Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, China.
Han F; Department of Radiation Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, China.
Ye WJ; Department of Radiation Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, China. .
Gao YH; Department of Radiation Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, China. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2020 Jun 05; Vol. 15 (1), pp. 142. Date of Electronic Publication: 2020 Jun 05.
Typ publikacji:
Journal Article
MeSH Terms:
Nasopharyngeal Carcinoma/*radiotherapy
Nasopharyngeal Neoplasms/*radiotherapy
Nasopharynx/*pathology
Radiotherapy/*adverse effects
Radiotherapy/*methods
Adult ; Aged ; Constriction, Pathologic/etiology ; Female ; Humans ; Male ; Middle Aged ; Nasopharynx/radiation effects ; Radiation Injuries/etiology ; Radiometry ; Radiotherapy Dosage ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł:
Prognostic model and optimal treatment for patients with stage IVc nasopharyngeal carcinoma at diagnosis.
Autorzy:
Tian YM; Department of Radiation Oncology, Hui Zhou Municipal Central Hospital, Guangdong Province, China. .
Huang WZ; Department of Medical Oncology, Hui Zhou Municipal Central Hospital, Guangdong Province, China.
Lan YH; Department of Radiation Oncology, Hui Zhou Municipal Central Hospital, Guangdong Province, China.
Zhao C; Department of Radiation Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Guangzhou, China.
Bai L; Department of Radiation Oncology, Hui Zhou Municipal Central Hospital, Guangdong Province, China. .
Han F; Department of Radiation Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Guangzhou, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Dec 17; Vol. 9 (1), pp. 19272. Date of Electronic Publication: 2019 Dec 17.
Typ publikacji:
Clinical Trial; Journal Article; Validation Study
MeSH Terms:
Chemoradiotherapy*
Models, Biological*
Nasopharyngeal Carcinoma*/mortality
Nasopharyngeal Carcinoma*/pathology
Nasopharyngeal Carcinoma*/therapy
Nasopharyngeal Neoplasms*/mortality
Nasopharyngeal Neoplasms*/pathology
Nasopharyngeal Neoplasms*/therapy
Adolescent ; Adult ; Aged ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Predictive Value of Tests ; Survival Rate
Czasopismo naukowe
Tytuł:
Clinical characteristics and prognostic value of pre-retreatment plasma epstein-barr virus DNA in locoregional recurrent nasopharyngeal carcinoma.
Autorzy:
Liu MZ; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Province, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong Province, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong Province, People's Republic of China.
Fang SG; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Province, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong Province, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong Province, People's Republic of China.
Huang W; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Province, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong Province, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong Province, People's Republic of China.
Wang HY; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Province, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong Province, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong Province, People's Republic of China.
Tian YM; Department of Radiation Oncology, Hui Zhou Municipal Centre Hospital, Huizhou, Guangdong Province, People's Republic of China.
Huang RD; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Province, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong Province, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong Province, People's Republic of China.
Sun Z; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Province, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong Province, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong Province, People's Republic of China.
Zhao C; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Province, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong Province, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong Province, People's Republic of China.
Lu TX; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Province, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong Province, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong Province, People's Republic of China.
Huang Y; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Province, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong Province, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong Province, People's Republic of China.
Han F; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Province, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong Province, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong Province, People's Republic of China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2019 Aug; Vol. 8 (10), pp. 4633-4643. Date of Electronic Publication: 2019 Jul 03.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
DNA, Viral/*blood
Epstein-Barr Virus Infections/*epidemiology
Herpesvirus 4, Human/*genetics
Nasopharyngeal Carcinoma/*virology
Nasopharyngeal Neoplasms/*virology
Neoplasm Recurrence, Local/*virology
Adult ; Aged ; Chemoradiotherapy/statistics & numerical data ; Cohort Studies ; Epstein-Barr Virus Infections/diagnosis ; Epstein-Barr Virus Infections/therapy ; Female ; Humans ; Male ; Middle Aged ; Nasopharyngeal Carcinoma/therapy ; Nasopharyngeal Neoplasms/therapy ; Neoplasm Recurrence, Local/therapy ; Otorhinolaryngologic Surgical Procedures/statistics & numerical data ; Prognosis ; Radiotherapy/statistics & numerical data ; Retrospective Studies ; Survival Rate ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis.
Autorzy:
Lan M; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Department of Radiation Oncology, Guangzhou, China.
Chen C; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Department of Radiation Oncology, Guangzhou, China.
Huang Y; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Department of Radiation Oncology, Guangzhou, China.
Tian L; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Imaging Diagnosis and Interventional Center, Guangzhou, China.
Duan Z; Chengdu Military General Hospital, Department of Radiation Diagnosis and Interventional Center, Chengdu, China.
Han F; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Department of Radiation Oncology, Guangzhou, China.
Liao J; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Department of Radiation Oncology, Guangzhou, China.
Deng M; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Department of Radiation Oncology, Guangzhou, China.
Sio TT; Mayo Clinic, Department of Radiation Oncology, Scottsdale, Arizona.
Prayongrat A; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, King Bangkok, Thailand.
Zheng L; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Imaging Diagnosis and Interventional Center, Guangzhou, China.
Wu S; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Department of Radiation Oncology, Guangzhou, China.
Lu T; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Department of Radiation Oncology, Guangzhou, China.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2017 Feb 17; Vol. 7, pp. 42624. Date of Electronic Publication: 2017 Feb 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*therapeutic use
Carcinoma/*therapy
Chemoradiotherapy/*methods
Combined Modality Therapy/*methods
Nasopharyngeal Neoplasms/*therapy
Necrosis/*therapy
Neoadjuvant Therapy/*methods
Adult ; Carcinoma/diagnostic imaging ; Carcinoma/mortality ; Carcinoma/pathology ; Cervical Vertebrae/diagnostic imaging ; Cervical Vertebrae/pathology ; Chemoradiotherapy/adverse effects ; Female ; Follow-Up Studies ; Humans ; Leukopenia/etiology ; Leukopenia/mortality ; Leukopenia/pathology ; Lymph Nodes/diagnostic imaging ; Lymph Nodes/pathology ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Mucositis/etiology ; Mucositis/mortality ; Mucositis/pathology ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms/diagnostic imaging ; Nasopharyngeal Neoplasms/mortality ; Nasopharyngeal Neoplasms/pathology ; Necrosis/diagnostic imaging ; Necrosis/mortality ; Necrosis/pathology ; Neoadjuvant Therapy/adverse effects ; Neoplasm Staging ; Patient Compliance ; Retrospective Studies ; Survival Analysis
Czasopismo naukowe
Tytuł:
Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.
Autorzy:
Wu S; Department of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, P. R. China; Hubei Cancer Clinical Study Center, Wuhan University, Wuhan, Hubei, P. R. China; Department of Radiation Oncology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang, P. R. China.
Xia B; Department of Radiation Oncology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang, P. R. China.
Han F; State Key Laboratory of Oncology in Southern China, Guangzhou, P. R. China; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, P. R. China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, P. R. China.
Xie R; Department of Radiation Oncology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang, P. R. China.
Song T; Department of Radiation Oncology, Wenzhou Medical College Cancer Center, Wenzhou, Zhejiang, P. R. China.
Lu L; State Key Laboratory of Oncology in Southern China, Guangzhou, P. R. China; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, P. R. China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, P. R. China.
Yu W; Department of Radiation Oncology, Wenzhou Medical College Cancer Center, Wenzhou, Zhejiang, P. R. China.
Deng X; State Key Laboratory of Oncology in Southern China, Guangzhou, P. R. China; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, P. R. China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, P. R. China.
He Q; Department of Radiation Oncology, Wenzhou Medical College Cancer Center, Wenzhou, Zhejiang, P. R. China.
Zhao C; State Key Laboratory of Oncology in Southern China, Guangzhou, P. R. China; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, P. R. China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, P. R. China.
Xie C; Department of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, P. R. China; Hubei Cancer Clinical Study Center, Wuhan University, Wuhan, Hubei, P. R. China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Aug 06; Vol. 10 (8), pp. e0134491. Date of Electronic Publication: 2015 Aug 06 (Print Publication: 2015).
Typ publikacji:
Journal Article
MeSH Terms:
Radiotherapy, Intensity-Modulated*
Nasopharyngeal Neoplasms/*radiotherapy
Adolescent ; Adult ; Aged ; Carcinoma ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms/mortality ; Nasopharyngeal Neoplasms/pathology ; Neoplasm Staging ; Nomograms ; Proportional Hazards Models ; Retrospective Studies ; Tomography, X-Ray Computed ; Young Adult
Czasopismo naukowe
Tytuł:
Prognostic significance of tumor volume in locally recurrent nasopharyngeal carcinoma treated with salvage intensity-modulated radiotherapy.
Autorzy:
Xiao W; Department of Radiotherapy, SunYat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China.
Liu S; Department of Radiotherapy, SunYat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China.
Tian Y; Department of Radiation Oncology, Hui Zhou Municipal Central Hospital, Huizhou, Guangdong, China.
Guan Y; Department of Radiotherapy, SunYat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China.
Huang S; Department of Radiotherapy, SunYat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China.
Lin C; Department of Radiotherapy, SunYat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China.
Zhao C; Department of Radiotherapy, SunYat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China.
Lu T; Department of Radiotherapy, SunYat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China.
Han F; Department of Radiotherapy, SunYat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Apr 30; Vol. 10 (4), pp. e0125351. Date of Electronic Publication: 2015 Apr 30 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Radiotherapy, Intensity-Modulated*
Nasopharyngeal Neoplasms/*pathology
Nasopharyngeal Neoplasms/*radiotherapy
Adult ; Aged ; Carcinoma ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms/mortality ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Prognosis ; Retreatment ; Salvage Therapy ; Treatment Outcome ; Tumor Burden ; Young Adult
Czasopismo naukowe
Tytuł:
Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
Autorzy:
Zheng Y; Department of Radiotherapy, Beijing Chaoyang Hospital, Affiliated to Capital Medical University, Beijing, 100020, PR China. .
Han F; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, PR China. .
Xiao W; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, PR China. .
Xiang Y; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, PR China. .
Lu L; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, PR China. .
Deng X; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, PR China. .
Cui N; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, PR China. .
Zhao C; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, PR China. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2015 Jan 13; Vol. 10, pp. 17. Date of Electronic Publication: 2015 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
Nasopharyngeal Neoplasms/*radiotherapy
Radiotherapy, Intensity-Modulated/*adverse effects
Xerostomia/*etiology
Adolescent ; Adult ; Aged ; Carcinoma ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms/pathology ; Neoplasm Staging ; Prognosis ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted/methods ; Time Factors ; Xerostomia/diagnosis ; Young Adult
Czasopismo naukowe
Tytuł:
Retrospective analysis of 234 nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis: therapeutic approaches and prognostic factors.
Autorzy:
Zeng L; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, PR China; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, PR China; Department of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, PR China.
Tian YM; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, PR China; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, PR China.
Huang Y; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, PR China.
Sun XM; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, PR China.
Wang FH; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, PR China.
Deng XW; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, PR China.
Han F; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, PR China.
Lu TX; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, PR China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Sep 23; Vol. 9 (9), pp. e108070. Date of Electronic Publication: 2014 Sep 23 (Print Publication: 2014).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma/*secondary
Liver Neoplasms/*secondary
Lung Neoplasms/*secondary
Nasopharyngeal Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carcinoma/drug therapy ; Carcinoma/mortality ; Carcinoma/radiotherapy ; Combined Modality Therapy ; Female ; Humans ; Liver Neoplasms/drug therapy ; Liver Neoplasms/mortality ; Liver Neoplasms/radiotherapy ; Lung Neoplasms/drug therapy ; Lung Neoplasms/mortality ; Lung Neoplasms/radiotherapy ; Male ; Middle Aged ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms/drug therapy ; Nasopharyngeal Neoplasms/mortality ; Nasopharyngeal Neoplasms/radiotherapy ; Prognosis ; Retrospective Studies ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Autorzy:
Li JX
Huang SM
Jiang XH
Ouyang B
Han F
Liu S
Wen BX
Lu TX; Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, and State Key Laboratory of Oncology in Southern China, 651 Dongfeng Road East, Guangzhou 510060, P,R, China. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2014 Mar 27; Vol. 9, pp. 87. Date of Electronic Publication: 2014 Mar 27.
Typ publikacji:
Journal Article
MeSH Terms:
Radiotherapy, Intensity-Modulated*
Nasopharyngeal Neoplasms/*diagnosis
Nasopharyngeal Neoplasms/*radiotherapy
Neoplasm Recurrence, Local/*diagnosis
Adult ; Aged ; Carcinoma ; Female ; Follow-Up Studies ; Humans ; Magnetic Resonance Spectroscopy ; Male ; Middle Aged ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms/pathology ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/pathology ; Radiotherapy Dosage ; Treatment Failure ; Tumor Burden ; Young Adult
Czasopismo naukowe
Tytuł:
Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy.
Autorzy:
Tian YM; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.
Tian YH; 1] Cancer Research Institute, Southern Medical University, Guangzhou, Guangdong Province, People's Republic of China [2] Department of Oncology, Armed Police Hospital of Guangdong Province, Guangzhou, Guangdong Province, People's Republic of China.
Zeng L; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.
Liu S; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.
Guan Y; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.
Lu TX; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.
Han F; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, People's Republic of China.
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2014 Jan 21; Vol. 110 (2), pp. 297-303. Date of Electronic Publication: 2013 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
Nasopharyngeal Neoplasms/*mortality
Nasopharyngeal Neoplasms/*radiotherapy
Neoplasm Recurrence, Local/*mortality
Neoplasm Recurrence, Local/*radiotherapy
Adult ; Aged ; Carcinoma ; Female ; Humans ; Male ; Middle Aged ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms/drug therapy ; Nasopharyngeal Neoplasms/pathology ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Radiotherapy, Intensity-Modulated/methods ; Retrospective Studies ; Survival Rate ; Young Adult
Czasopismo naukowe
Tytuł:
Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors.
Autorzy:
Zeng L; 1] State Key Laboratory Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, People's Republic of China [2] Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, 651 Dong Feng Road East, Guangzhou, People's Republic of China.
Tian YM; 1] State Key Laboratory Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, People's Republic of China [2] Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, 651 Dong Feng Road East, Guangzhou, People's Republic of China.
Sun XM; 1] State Key Laboratory Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, People's Republic of China [2] Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, 651 Dong Feng Road East, Guangzhou, People's Republic of China.
Chen CY; 1] State Key Laboratory Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, People's Republic of China [2] Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, 651 Dong Feng Road East, Guangzhou, People's Republic of China.
Han F; 1] State Key Laboratory Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, People's Republic of China [2] Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, 651 Dong Feng Road East, Guangzhou, People's Republic of China.
Xiao WW; 1] State Key Laboratory Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, People's Republic of China [2] Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, 651 Dong Feng Road East, Guangzhou, People's Republic of China.
Deng XW; 1] State Key Laboratory Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, People's Republic of China [2] Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, 651 Dong Feng Road East, Guangzhou, People's Republic of China.
Lu TX; 1] State Key Laboratory Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, People's Republic of China [2] Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, 651 Dong Feng Road East, Guangzhou, People's Republic of China.
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2014 Jan 07; Vol. 110 (1), pp. 49-54. Date of Electronic Publication: 2013 Nov 19.
Typ publikacji:
Journal Article
MeSH Terms:
Nasopharyngeal Neoplasms/*radiotherapy
Radiation Injuries/*etiology
Adolescent ; Adult ; Aged ; Carcinoma ; China/epidemiology ; Dose-Response Relationship, Radiation ; Female ; Humans ; Male ; Middle Aged ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms/epidemiology ; Nasopharyngeal Neoplasms/pathology ; Neoplasm Staging ; Radiation Injuries/epidemiology ; Radiotherapy, Intensity-Modulated/adverse effects ; Radiotherapy, Intensity-Modulated/statistics & numerical data ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł:
Prognostic factors in nasopharyngeal carcinoma with synchronous liver metastasis: a retrospective study for the management of treatment.
Autorzy:
Tian YM; State Key Laboratory of Oncolo-gy in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China. .
Zeng L
Wang FH
Liu S
Guan Y
Lu TX
Han F
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2013 Nov 19; Vol. 8, pp. 272. Date of Electronic Publication: 2013 Nov 19.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Neoplasms/*secondary
Nasopharyngeal Neoplasms/*drug therapy
Nasopharyngeal Neoplasms/*radiotherapy
Adult ; Aged ; Antineoplastic Agents/therapeutic use ; Carcinoma ; Combined Modality Therapy/methods ; Disease Progression ; Disease-Free Survival ; Female ; Humans ; L-Lactate Dehydrogenase/metabolism ; Liver Neoplasms/drug therapy ; Liver Neoplasms/radiotherapy ; Male ; Middle Aged ; Multivariate Analysis ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms/mortality ; Neoplasm Metastasis ; Prognosis ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy.
Autorzy:
Su SF; Department of Oncology, Affiliated Hospital of Guiyang Medical College, Guizhou Cancer Hospital, Guiyang, China.
Huang SM
Han F
Huang Y
Chen CY
Xiao WW
Sun XM
Lu TX
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2013 Jan 22; Vol. 8, pp. 17. Date of Electronic Publication: 2013 Jan 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Nasopharyngeal Neoplasms/*radiotherapy
Radiotherapy, Intensity-Modulated/*adverse effects
Temporal Lobe/*radiation effects
Adolescent ; Adult ; Aged ; Carcinoma ; Female ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms/pathology ; Necrosis ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted ; Temporal Lobe/pathology
Czasopismo naukowe
    Wyświetlanie 1-16 z 16

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies